AP
IMI

AlpInvest Partners’s Intermolecular, Inc. IMI Stock Holding History

AlpInvest Partners’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-19,029
Closed -$19K – 30
2018
Q4 		$19K Buy
+19,029
New +$19.1K 0.05% 23

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

AlpInvest Partners's IMI Position: Q1 2019 in Review

AlpInvest Partners sold out of Intermolecular, Inc. (IMI) in Q1 2019, closing a stake of 19,029 shares — an estimated $19K sold.

AlpInvest Partners first reported a position in IMI in Q4 2018 and held it in 1 quarter. The position peaked at $19K in Q4 2018. 28 funds tracked by Wall St. Rank hold IMI as of Q1 2019.

  • AlpInvest Partners reported no remaining Intermolecular, Inc. position as of Q1 2019 after selling out during the quarter.
  • AlpInvest Partners sold 19,029 Intermolecular, Inc. shares in Q1 2019, an estimated $19K.
  • AlpInvest Partners first reported a position in Intermolecular, Inc. in Q4 2018 and held it in 1 quarter.
  • AlpInvest Partners's Intermolecular, Inc. position peaked at $19K in Q4 2018.
  • 28 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q1 2019.

Based on AlpInvest Partners's 13F filing for Q1 2019, filed 13 May 2019.